12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Monday's intraday session. Notable gainers included Mallinckrodt (MNK), GoodRx Holdings (GDRX), SmileDirectClub (SDC), Enochian BioSciences (ENOB), Better Therapeutics (BTTX), and Adial Pharmaceuticals (ADIL). On the other hand, Marker Therapeutics (MRKR), OKYO Pharma (OKYO), Apellis Pharmaceuticals (APLS), Bluejay Diagnostics (BJDX), Checkpoint Therapeutics (CKPT), and Bionomics (BNOX) saw their stock prices decline.
July 31, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apellis Pharmaceuticals' shares fell 20.59% to $25.43.
The significant decrease in Apellis Pharmaceuticals' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bluejay Diagnostics' shares fell 17.63% to $6.45.
The significant decrease in Bluejay Diagnostics' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bionomics' stock declined by 11.52% to $1.69.
The significant decrease in Bionomics' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Checkpoint Therapeutics' shares declined by 16.46% to $2.59.
The significant decrease in Checkpoint Therapeutics' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Marker Therapeutics' shares fell 23.6% to $4.94.
The significant decrease in Marker Therapeutics' stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
OKYO Pharma's stock declined by 22.28% to $1.71.
The significant decrease in OKYO Pharma's stock price is likely to have a negative impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Adial Pharmaceuticals' stock rose 18.35% to $0.32.
The significant increase in Adial Pharmaceuticals' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Better Therapeutics' shares moved upwards by 19.19% to $0.74.
The significant increase in Better Therapeutics' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Enochian BioSciences' stock increased by 21.34% to $0.69.
The significant increase in Enochian BioSciences' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
GoodRx Holdings' stock moved upwards by 34.8% to $9.1.
The significant increase in GoodRx Holdings' stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Mallinckrodt's stock rose 41.7% to $1.53 during Monday's session.
The significant increase in Mallinckrodt's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SmileDirectClub's stock rose 22.42% to $0.86.
The significant increase in SmileDirectClub's stock price is likely to have a positive impact on its short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100